Condition: Rhinitis, Allergic · Rhinoconjunctivitis · Asthma, Allergic · Sponsor: Inmunotek S.L.
A double-blinded, placebo-controlled, prospective, multicenter randomized of 2 active treatment groups, compared to 1 placebo group, for the determination of the efficacy and safety of subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophagoides farinae.
This description comes directly from the study's public registry record.
Miguel Casanovas, MD PhD · +34916510010 · mcasanovas@inmunotek.com
Raquel Caballero, MD · +34607600638 · rcaballero@inmunotek.com
Always discuss trial participation with your own doctor first.
| Hospital Provincial de Conxo | Santiago de Compostela, A Coruña, Spain | Recruiting |
| IMED Elche | Elche, Alicante, Spain | Recruiting |
| Hospital Universitario de Torrevieja | Torrevieja, Alicante, Spain | Recruiting |
| Clinica Tecma | Valencia, Alzira, Spain | Completed |
| Clinica Virgen del Rosario | Algeciras, Cadiz, Spain | Active Not Recruiting |
| Hospital HLA Jerez Puerta Sur | Jerez de la Frontera, Cádiz, Spain | Withdrawn |
| Hospital Dr. Peset | Valencia, España, Spain | Recruiting |
| Hospital General Universitario Santa Maria de Rosell | Cartagena, Murcia, Spain | Withdrawn |
| Hospital Rivera Povisa | Vigo, Pontevedra, Spain | Active Not Recruiting |
| Hospital General Universitario Dr. Balmis | Alicante, Spain | Recruiting |
| Hospital Universitario San Juan de Alicante | Alicante, Spain | Recruiting |
| Clínica Dermatológica y Alergia | Badajoz, Spain | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04435990